Lower Risk of Multisystem Inflammatory Syndrome in Children With the Delta and Omicron Variants of Severe Acute Respiratory Syndrome Coronavirus 2
Open Access
- 5 July 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 76 (3) , e518-e521
Abstract
Little is known about the risk of multisystem inflammatory syndrome in children (MIS-C) with different severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. In southeast England, MIS-C rates per confirmed SARS-CoV-2 infections in children aged 0–16 years were 56% lower (rate ratio [RR], 0.34 [95% confidence interval {CI}, .23–.50]) during prevaccine Delta, 66% lower (RR, 0.44 [95% CI, .28–.69]) during postvaccine Delta, and 95% lower (RR, 0.05 [95% CI, .02–.10]) during the Omicron period.Keywords
All Related Versions
This publication has 4 references indexed in Scilit:
- Multisystem inflammatory syndrome in children occurred in one of four thousand children with severe acute respiratory syndrome coronavirus 2Acta Paediatrica, 2021
- Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2JAMA Network Open, 2021
- Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammationProceedings of the National Academy of Sciences, 2020
- Hyperinflammatory shock in children during COVID-19 pandemicThe Lancet, 2020